You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

  Results, filtered by:  

Filter by

Resources
Search results for
1 - 0 of 156 items
28-11-2015

Respiratory

A comprehensive source of GSK respiratory information and services, designed to help you support your patients.
27-11-2015

Ellipta inhaler

Ellipta inhaler information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
21-11-2015

Anoro▼ Ellipta

Anoro▼ Ellipta (umeclidinium/vilanterol inhalation powder) information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
21-11-2015

Relvar▼ Ellipta

Relvar▼ Ellipta (fluticasone furoate/vilanterol) information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
21-11-2015

Twinrix Paediatric

Twinrix Paediatric (Hepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed)) information for Healthcare Professionals registered in Ireland <br>Vaccines</br>
21-11-2015

Twinrix Adult

Twinrix Adult (Hepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed)) information for Healthcare Professionals registered in Ireland <br>Vaccines</br>
21-11-2015

Havrix Junior Monodose

Havrix Junior Monodose (Hepatitis A Vaccine (inactivated, adsorbed)) information for Healthcare Professionals in Ireland <br>Vaccines</br>
21-11-2015

Incruse▼ Ellipta

Incruse Ellipta (umeclidinium inhalation powder) information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
21-11-2015

Havrix Monodose

Havrix Monodose (Hepatitis A Vaccine (inactivated, adsorbed)) information for Healthcare Professionals in Ireland <br>Vaccines</br>
21-11-2015

Avamys

Avamys (fluticasone furoate) information for Healthcare Professionals registered in Ireland <br>Allergy</br>
17-07-2017

Sitemap

GlaxoSmithKline (GSK) Ireland healthcare professional website site map.
13-09-2017

Events

GSK events information for Ireland healthcare professionals
28-09-2016

View Stocks

06-07-2017

EADV

27-09-2017

Homepage

GlaxoSmithKline (GSK) healthcare professional registered in Ireland website supporting healthcare professionals in their daily practice by providing information to aid patient treatment. The site provides information on all GSK products, latest GSK product news, links and may contain promotional information
10-04-2017

Tivicay▼

10-04-2017

HIV

Welcome to the HIV therapy area, for information and resources on dolutegravir and our HIV medicines (TRIUMEQ and TIVICAY).
10-04-2017

ViiV Healthcare CSR Programmes & Access Strategy

Access and download the latest information about dolutegravir and our HIV medicines (Triumeq and Tivicay).
23-06-2017

DTG At The Core

Videos and Resources to learn more about dolutegravir
23-06-2017

Booster Free

Videos and Resources to learn more about dolutegravir
23-06-2017

INI Metabolic Profile

Videos and Resources to learn more about dolutegravir
23-06-2017

Mode of Action

Videos and Resources to learn more about dolutegravir
10-04-2017

Videos

Videos and Resources to learn more about dolutegravir
23-06-2017

Meet David

Dramatisation of the impact of a HIV diagnosis and starting treatment with Triumeq
10-04-2017

Triumeq▼

23-06-2017

Challenges of ARV Treatment in Women Living with HIV

Videos and Resources to learn more about dolutegravir
10-04-2017

Meet Expert Webinars

Recording of recent webinars discussing topical issues in the treatment of HIV as well as our medicines.
23-06-2017

STRIIVING Study (48-Week Data)

Videos and Resources to learn more about dolutegravir
18-07-2017

Therapy areas

GSK therapy information for Ireland healthcare professionals
08-03-2017

Dermatology

Information on our dermatology products provided by Stiefel, a GSK company.
10-07-2017

Critical Errors with Ellipta - Asthma

Find out how critical errors with Ellipta compares to other commonly used asthma inhlaers
07-04-2017

SLS (Salford Lung Study) Key Results

Relvar▼Ellipta (fluticasone furoate/vilanterol) 92/22 mcg +/- LAMA reduces moderate/severe COPD exacerbations compared with usual care, or twice-daily ICS/LABA ± LAMA. More patients with COPD achieved improvement in their COPD-related health status with Relvar, compared with usual care.
14-07-2017

Knowledge base

13-06-2017

Products

18-07-2017

Urology

GSK Irish information about our urology portfolio, as well as resources and latest news.
22-08-2017

Our vaccines portfolio

View our range of flu, travel and paediatric/adolescent vaccines.
26-07-2017

Vaccines

GSK Ireland information about our vaccines portfolio, as well as resources and latest news.
03-07-2017

Update Password

24-07-2017

Token Sent

15-07-2017

Contact us

GSK contact page for healthcare professionals registered in Ireland
27-07-2017

Request a contact

19-05-2016

Event registration

30-06-2017

Seretide Evohaler

Seretide Evohaler (salmeterol xinafoate/ fluticasone propionate) information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
08-06-2017

Product information

15-07-2017

Lamictal

Lamictal (lamotrigine) information for Healthcare Professionals registered in Ireland <br>Neurology</br>
08-06-2017

Clinical evidence

15-07-2017

Dosage

Combodart (dutasteride/tamusolin hydrochloride) dosage information support Healthcare Professionals registered in Ireland in their daily practice.
15-07-2017

Combodart

Combodart (dutasteride / tamsulosin) information for Healthcare Professionals registered in Ireland <br>Urology</br>
15-07-2017

Safety

Combodart (dutasteride/tamusolin hydrochloride) safety information support Healthcare Professionals registered in Ireland in their daily practice.
15-07-2017

Efficacy

Combodart (dutasteride/tamusolin hydrochloride) efficacy information support Healthcare Professionals registered in Ireland in their daily practice.
17-10-2017

Patient Resources

Combodart (dutasteride/tamusolin hydrochloride) patient resources support Healthcare Professionals registered in Ireland in their daily practice.
15-07-2017

Indications

Combodart (dutasteride/tamusolin hydrochloride) indications information support Healthcare Professionals registered in Ireland in their daily practice.
27-07-2017

Clinical Presentation

Identifying various forms of acne – Information on the clinical presentation of acne.
15-07-2017

Duac

Duac (benzoyl peroxide, clindamycin phosphate) information for Healthcare Professionals registered in Ireland <br>Dermatology</br>
27-07-2017

Epidemiology

Acne is a common skin condition that can affect everyone, irrespective of age, gender or ethnicity.
27-07-2017

Duac: Clinical Evidence

Clinical evidence supporting the use of combination therapy Duac for the treatment of acne.
27-07-2017

Duac: How to Prescribe

Duac prescribing information
15-07-2017

Avodart

Avodart (dutasteride) information for Healthcare Professionals registered in Ireland <br>Urology</br>
29-07-2017

Ventolin overview

Information about Ventolin (inhaled salbutamol): for the treatment/prevention of bronchospasm due to asthma/chronic bronchitis/emphysema, provided by GSK.
29-07-2017

Product information

The range of Ventolin formulations for the treatment or prevention of bronchospasm: inhaler, nebules, respirator solution.
18-07-2017

Ventolin

Ventolin (salbutamol) information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
29-07-2017

Clinical evidence

Clinical evidence: efficacy of Ventolin (salbutamol) in providing rapid relief of asthma symptoms in adults and children.
05-07-2017

Volibris

Volibris (ambrisentan) information for Healthcare Professionals registered in Ireland <br>Medicine</br>
16-08-2017

Zyban

Zyban (bupropion hydrochlorid) information for Healthcare Professionals registered in Ireland <br>Neurology</br>
15-07-2017

Efficacy and safety

Anoro▼ (umeclidinium/vilanterol) efficacy and safety information support Healthcare Professionals registered in Ireland in their daily practice.
04-08-2017

Administration

Anoro▼ Ellipta (umeclidinium/vilanterol) administration and dosing information to Healthcare Professionals registered in Ireland in their daily practice.
08-08-2017

Patient Profile – Assessing Symptoms

Anoro▼ (umeclidinium/vilanterol) indication information support Healthcare Professionals registered in Ireland in their daily practice.
15-07-2017

Indications

Anoro▼ (umeclidinium/vilanterol) indication information support Healthcare Professionals registered in Ireland in their daily practice.
19-07-2017

Imigran

Imigran (sumatriptan) information for Healthcare Professionals registered in Ireland <br>Neurology</br>
06-07-2017

Priorix

Priorix (measles, mumps and rubella vaccine (live)) information for Healthcare Professionals registered in Ireland <br>Vaccines</br>
18-07-2017

Incruse and Relvar Ellipta

Incruse▼ (umeclidinium bromide inhalation powder) Incruse and Relvar▼ Ellipta (fluticasone furoate/vilanterol) combination therapy information to support Irish healthcare professionals in their daily practice.
10-08-2017

Administration

Incruse▼ (umeclidinium bromide inhalation powder) administration and dosing information to support Healthcare Professionals registered in Ireland in their daily practice.
06-07-2017

Efficacy and safety

Incruse▼ (umeclidinium bromide inhalation powder) efficacy and safety information to support Healthcare Professionals registered in Ireland in their daily practice.
06-07-2017

Indications

Incruse▼ (umeclidinium bromide inhalation powder) indication information to support Healthcare Professionals registered in Ireland in their daily practice.
07-04-2017

Overview

Havrix Monodose and Havrix Junior Monodose – indications, efficacy, administration and adverse event information.
12-04-2017

Tivicay Overview

Access the latest resources and learn how to prescribe Tivicay (Dolutegravir).
10-04-2017

Safety & Tolerability

Access the latest resources and learn how to prescribe Tivicay (Dolutegravir)
08-05-2017

Indication & Dosage

Access the latest resources and learn how to prescribe Triumeq (Dolutegravir)
10-04-2017

FLAMINGO Study

Once-daily Dolutegravir versus Darunavir plus ritonavir in antiretroviral-naïve adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
10-04-2017

SINGLE Study

Dolutegravir Plus Abacavir/Lamivudine for the treatment of HIV-1 Infection in Antiretroviral Therapy-Naïve Patients: Week 96 and Week 144. Results from the SINGLE Randomised Clinical Trial
10-04-2017

SPRING 2 Study

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naïve adults with HIV-1 infection (SPRING-2 Study): 96 week results from a randomised, double-blind, non-inferiority trial Raffi F, Jaeger H, Quiros-Roldan E, et al, on behalf of the extended SPRING-2 Study Group Lancet Infect Dis 203; 13: 927-935
10-04-2017

SAILING Study

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naïve adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study Cahn P, Pozniak AL, Mingrone H, et al, on behalf of the extended SAILING Study Team Lancet 2013; 382: 700-708
10-04-2017

VIKING 3 Study

Dolutegravir in Antiretroviral-Experienced Patients with Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
01-08-2017

Data & Resources

Access the latest resources and learn how to prescribe Tivicay (dolutegravir).
10-04-2017

Published Manuscripts

Access the latest resources and learn how to prescribe Tivicay (dolutegravir).
01-08-2017

Slide Sets

03-08-2017

ppt

03-08-2017

Slide Sets

Access the latest data for Tivicay(dolutegravir)
01-08-2017

Tivicay

Tivicay (dolutegravir) information for Healthcare Professionals registered in Ireland <br>HIV</br>
10-04-2017

Drug-drug Interactions

Access the latest resources and learn how to prescribe Tivicay (Dolutegravir)
30-06-2017

Flolan – pH12 Solvent

Flolan – pH12 Solvent (epoprostenol sodium) information for Healthcare Professionals registered in Ireland <br>Medicine</br>
28-03-2017

HCP Educational Materials

Links to the Flolan Summary of Product Characteristics (SPC), Patient Information Leaflet (PIL) and educational materials for Healthcare Professionals in Ireland
15-07-2017

Efficacy and safety

Relvar▼ Ellipta (fluticasone furoate/vilanterol) efficacy and safety information to support Healthcare Professionals registered in Ireland in their daily practice.
04-07-2017

SLS (Salford Lung Study) Key Results

Relvar▼Ellipta (fluticasone furoate/vilanterol) 92/22 mcg +/- LAMA reduces moderate/severe COPD exacerbations compared with usual care, or twice-daily ICS/LABA ± LAMA. More patients with COPD achieved improvement in their COPD-related health status with Relvar, compared with usual care.
04-07-2017

Administration

Relvar▼ Ellipta (fluticasone furoate/vilanterol) administration and dosing information to Healthcare Professionals registered in Ireland in their daily practice.
15-07-2017

Indications

Relvar▼ Ellipta (fluticasone furoate/vilanterol) indication information to support Healthcare Professionals registered in Ireland in their daily practice.
25-09-2017

Products

GSK product information for Ireland healthcare professionals
28-04-2017

Twinrix overview

Indication, administration, efficacy and safety information for Twinrix.
10-04-2017

Safety &Tolerability

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine)
10-04-2017

Statistically Superior Efficacy

Overview of the Efficacy Data supporting Triumeq (dolutegravir/abacavir/lamivudine)
10-04-2017

Booster Free Dosing

Overview of benefits associated with booster-free dosing (dolutegravir/abacavir/lamivudine)
10-04-2017

Overview

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine)
10-04-2017

High Barrier to Resistance

Overview of the high barrier to resistance with Triumeq (dolutegravir/abacavir/lamivudine)
10-04-2017

Published Manuscripts

Access the latest data for Triumeq (dolutegravir/abacavir/lamivudine).
10-04-2017

SINGLE study 144 weeks

Dolutegravir Plus Abacavir/Lamivudine for the treatment of HIV-1 Infection in Antiretroviral Therapy-Naïve Patients: Week 96 and Week 144. Results from the SINGLE Randomised Clinical Trial
10-04-2017

ARIA study

Once-daily TRIUMEQ compared with ritonavir boosted atazanavir plus tenofovir disoproxil fumarate/emtricitabine in treatment-naime women with HIV-1 infection (ARIA Study)
10-04-2017

Data & Resources

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine)
03-08-2017

ppt

03-08-2017

Slide Sets

Access the latest data for Triumeq (dolutegravir/abacavir/lamivudine).
10-04-2017

STRIIVING Study Abstract – an update from IAC 2016

STRIIVING: Switching to Abacavir/Dolutegravir/Lamivudine Fixed Dose Combination (ABC/DTG/3TC FDC) from a PI, NNRTI or INI-Based Regimen Maintains HIV Suppression at Week 48
10-04-2017

FLAMINGO study

Once-daily Dolutegravir versus Darunavir plus ritonavir in antiretroviral-naïve adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
30-06-2017

Triumeq

Triumeq▼ (dolutegravir / abacavir / lamivudine) information for Healthcare Professionals registered in Ireland <br>HIV</br>
10-04-2017

Indication & Dosage

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine)
10-04-2017

HLA-B*5701 Screening

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine)
12-04-2017

Drug-drug Interactions

Access the latest resources and learn how to prescribe Triumeq (dolutegravir/abacavir/lamivudine)
27-07-2017

Overview

Overview of Bexsero▼ for Healthcare Professionals registered in Ireland
15-07-2017

Bexsero▼

Bexsero▼ (meningococcal group-B vaccine (rDNA, component, adsorbed)) information for Healthcare Professionals registered in Ireland <br>Vaccines</br>
27-07-2017

Disease Burden

Information on Invasive Meningococcal Disease (IMD) for Healthcare Professionals registered in Ireland.
27-07-2017

Reverse Vaccinology

27-07-2017

Immunogenicity & Safety

Summary of Bexsero▼ Immunogenicity & safety data for Healthcare Professionals registered in Ireland
19-07-2017

Requip Modutab

Requip Modutab (ropinirole hydrochloride) information for Healthcare Professionals registered in Ireland <br>Neurology</br>
18-07-2017

How to prescribe Seretide

Key prescribing information for Seretide (salmeterol xinafoate/fluticasone propionate) to support healthcare professionals registered in Ireland
18-07-2017

Seretide in paediatric patients

Find out how Seretide could be used to treat the symptoms of asthma in paediatric patients aged four and above.
18-07-2017

Seretide

Seretide (salmeterol xinafoate / fluticasone propionate) information for Healthcare Professionals registered in Ireland <br>Respiratory</br>
18-07-2017

Seretide evidence

Evidence to support Healthcare professionals registered in Ireland in the use of seretide in asthma and COPD
15-07-2017

Fendrix

Fendrix (hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)) information for Healthcare Professionals registered in Ireland <br>Vaccines</br>
15-07-2017

Amoxil

Amoxil (amoxicillin) information for Healthcare Professionals registered in Ireland <br>Anti-infectives</br>
30-06-2017

Rotarix

Rotarix (rotavirus vaccine, live) information for Healthcare Professionals registered in Ireland <br>Vaccines</br>
04-08-2017

Rotavirus Module 5

Module 5 of the online learning modules for the Rotavirus Vaccine
04-08-2017

Compliance with vaccination schedules

Rotavirus Online Training Resources
04-08-2017

Rotavirus and nosocomial infection

Rotavirus Online Training Resources
04-08-2017

Introducing Rotavirus Vaccine to immunisation schedules.

Rotavirus Online Training Resources
04-08-2017

Consequences of rotavirus infection on society

Rotavirus Online Training Resources
04-08-2017

The impact of rotavirus on families

Rotavirus Online Training Resources
04-08-2017

The need for early rotavirus vaccination

Rotavirus Online Training Resources
04-08-2017

Universal mass vaccination

Rotavirus Online Training Resources
04-08-2017

Rotavirus Online Training Resources

Rotavirus Online Training Resources
04-08-2017

Vaccination and severe rotavirus gastroenteritis.

Rotavirus Online Training Resources
04-08-2017

Rotavirus Module 3

Module 3 of the online learning modules for the Rotavirus Vaccine
25-07-2017

Rotavirus Module 4

Module 4 of the online learning modules for the Rotavirus Vaccine
04-08-2017

Rotavirus Module 1

Module 1 of the Online learning modules for the Rotavirus Vaccine
04-08-2017

Overview page for Rotavirus online training modules

Overview page of the online learning modules for the Rotavirus Vaccine
04-08-2017

Rotavirus Module 2

Module 2 of the online learning modules for the Rotavirus Vaccine
23-08-2017

Resources

GSK resources information for Ireland healthcare professionals
22-08-2017

ppt

22-08-2017

Chemsex Webinar

Videos and Resources to learn more about dolutegravir
24-08-2017

Indications

Augmentin® (amoxicillin-clavulanate) is indicated for a wide range of infections. This comprehensive information is designed to help healthcare professionals in daily practice.
28-08-2017

Efficacy

A comprehensive source of information on the efficacy of Augmentin® (amoxicillin-clavulanate), designed to help healthcare professionals in their daily practice
11-09-2017

HIV and Aging

Videos and Resources to learn more about dolutegravir
11-09-2017

Children and HIV

Videos and Resources to learn more about dolutegravir
25-09-2017

VIIV @ IAS 2017

Videos and Resources to learn more about dolutegravir
25-09-2017

Women & HIV

Videos and Resources to learn more about dolutegravir
25-09-2017

Augmentin

Augmentin (amoxicillin, clavulanate) information for Healthcare Professionals registered in Ireland<br>Anti-infectives</br>
1 - 0 of 156 items

Show more

Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

JD. February 2017. IE/COM/0012/16a(1)